BioStem Technologies, Inc. (BSEM)
OTCMKTS · Delayed Price · Currency is USD
4.110
-0.315 (-7.12%)
At close: Mar 30, 2026
BioStem Technologies Market Cap
BioStem Technologies has a market cap or net worth of $69.27 million as of March 30, 2026. Its market cap has decreased by -61.35% in one year.
Market Cap
69.27M
Enterprise Value
43.06M
Revenue
47.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.11
Market Cap Chart
Since August 4, 2009, BioStem Technologies's market cap has increased from 4.77M to 69.27M, an increase of 1,350.99%. That is a compound annual growth rate of 17.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 69.27M | 8.23% |
| Dec 31, 2025 | 64.01M | -72.22% |
| Dec 31, 2024 | 230.43M | 143.12% |
| Dec 29, 2023 | 94.78M | 160.66% |
| Dec 30, 2022 | 36.36M | 267.00% |
| Dec 30, 2021 | 9.91M | -25.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 232.86M |
| Vaxart | 156.38M |
| HST Global | 88.40M |
| Nuo Therapeutics | 69.54M |
| Anebulo Pharmaceuticals | 36.17M |
| Cell Source | 34.99M |
| Vicapsys Life Sciences | 32.05M |
| Harvard Apparatus Regenerative Technology | 29.49M |